Proud to see ADMA Biologics recognized by Nasdaq following the expanded indication approval for ASCENIV. Thank you to Nasdaq for highlighting this important milestone — a reflection of the dedication and commitment behind advancing care for patients living with primary immunodeficiency. A meaningful achievement for the entire ADMA team! Read the full press release here: https://lnkd.in/ezKkxpzg
ADMA Biologics, Inc.
Biotechnology Research
Ramsey, NJ 11,254 followers
Hiring at our Boca Raton, FL campus!
About us
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
- Website
-
http://www.admabiologics.com
External link for ADMA Biologics, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Ramsey, NJ
- Type
- Public Company
- Founded
- 2004
- Specialties
- Plasma Collection, Plasma Products, Pharmaceutical Manufacturing, Biologics, Biotechnology, Immune Deficiency, and Infectious Disease
Locations
-
Primary
Get directions
465 Route 17 South
Ramsey, NJ 07446, US
-
Get directions
5800 Park of Commerce Blvd., NW
Boca Raton, FL 33487, US
-
Get directions
166 Ernest W. Barrett Parkway, NE
Kennesaw, GA 30066, US
Employees at ADMA Biologics, Inc.
Updates
-
Register to watch Kelli Williams, MD, MPH discuss "Managing Recurrent Respiratory Tract Infections in Pediatric Patients with Primary Immunodeficiency" bit.ly/cis2026adma #CIS2026 #ADMA
-
-
ADMA Biologics announces U.S. FDA approval of expanded indications, marking an important milestone in an ongoing commitment to patients. Read the full press release to learn more. https://lnkd.in/ezKkxpzg
-
-
World PI Week is coming to a close. We marked the week at ADMA with a near-endless supply of candy, a PI quiz, and prizes—all in the spirit of raising awareness for Primary Immunodeficiency. The real impact goes beyond the fun. If even one more person gets closer to the care they need, it matters - this week and every week. Awareness isn’t just a moment. It’s impact 💜💚🩵 #WorldPIWeek #PrimaryImmunodeficiency
-
Primary Immunodeficiency (PI) is often invisible—but its impact is anything but. For many patients, the journey to diagnosis can take years, marked by recurring infections and uncertainty. This Primary Immunodeficiency Awareness Month, we are sharing Mimi’s story—a powerful reminder of what’s possible when patients are properly diagnosed and treated. From years of illness to living a full, vibrant life, her experience reflects the very real impact of awareness, advocacy, and access to care. A sincere thank you to Immune Deficiency Foundation for their continued partnership and commitment to the PI community. And a special thank you to Mimi, a dedicated Plasma Ambassador, for sharing her story and helping bring greater visibility to this often-overlooked condition. #PIAwarenessMonth #PrimaryImmunodeficiency #PatientStories
-
Register to watch Araceli Elizalde, MD, and Erin Pratt, MD, discuss "Personalizing Ig Therapy in Patients with PI" bit.ly/taais2026 #ADMA
-
-
Primary Immunodeficiency Awareness Month begins today 💙 This month is dedicated to raising awareness of Primary Immunodeficiency and the patients living with it. We’re starting by recognizing plasma donors — the first step in making treatment possible. Plasma donation is essential to creating therapies patients depend on, and every donation helps make a meaningful difference. #PIAwarenessMonth #PrimaryImmunodeficiency #PlasmaDonation
-
Last week we celebrated the most delicious math joke of the year—with donuts instead of pie. Why? Because like π, donuts are perfectly round… and infinitely enjoyable! Pi Day, at ADMA Biologics, is more than a celebration of the mathematical constant, it’s another reason to celebrate, honor, and advocate for our PI (Primary Immunodeficiency) patients. Take a look at a few moments from this year’s celebration! 🍩🍩🍩🍩🍩
-
Rare diseases may be individually uncommon, but together they affect millions of people and families. For those living with rare diseases, uncertainty can be constant—but so is the determination of the clinicians, donors, researchers, and industry teams working to change what’s possible. At ADMA Biologics, this mission is personal. It’s why we show up every day—to help expand options and stand alongside the rare disease community. 🩷💙💚💜 #RareDiseaseDay #RareDisease #Immunology #PatientsFirst
-
-
Attendees have traveled through snow and long journeys to be together in Philadelphia for AAAAI 2026—a testament to the dedication of this community. We’re proud to be part of it. Visit ADMA Biologics at Booth #1427 to connect with our team. #AAAAI2026 #Immunology #Biologics #HealthcareInnovation
-